secwatch.observer — SEC 8-K summary
======================================

Issuer:     Propanc Biopharma, Inc. (PPCB)
CIK:        0001517681
Form:       8-K
Filed at:   2024-12-20T23:59:59+00:00
Accession:  0001493152-24-051125
Event type: debt
Sentiment:  negative
Materiality: 0.30
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Propanc Biopharma raises ~$61k via two convertible notes with dilutive terms
----------------------------------------------------------------------------

- Dec 16 note: $22k principal ($20k proceeds), 8% interest, matures June 15, 2025; convertible at $0.0003/share (step-down to $0.0001).
- Dec 20 note: $49.2k principal ($41k proceeds), 15% one-time interest, due Oct 15, 2025; conversion at 65% of lowest 10-day trading price.
- Proceeds used for general working capital; notes are private placements under Rule 506.
- Note terms include 4.99% beneficial ownership cap and prepayment premiums up to 125% face value.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517681/000149315224051125/0001493152-24-051125-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517681/000149315224051125/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-051125

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer